Community/Retail

Bristol-Myers Squibb Company and Galecto Biotech AB today announced that the companies, together with the Galecto shareholders, have entered into an agreement that provides Bristol-Myers Squibb the exclusive option to acquire Galecto Biotech AB and gain worldwide rights to its lead asset TD139, a novel inhaled inhibitor of galectin-3 in Phase 1 development for the treatment of idiopathic pulmonary fibrosis and other pulmonary fibrotic conditions.

A Walgreens and Greenhouse Pharmacy situated in San Francisco were robbed of prescription medications on the eve of Halloween.

One of the most crucial roles in the fight to stop the spread of Ebola may be played by a mouse.

Although trans fat intake has dropped over the past 30 years, most American adults still consume more than the amount recommended by the American Heart Association (AHA).

In hospitals with antibiotic stewardship programs dedicated to the appropriate use of antibiotic prescriptions, children are discharged sooner and are less likely to be readmitted.

When examining the future of the Ebola virus, it is important to understand the epidemic in the context of similar outbreaks that occurred in the relatively recent past.

Will using HealthKit during the day keep adverse events away? Apple Inc. certainly hopes so.

The dangers of failing to change the clocks on insulin pumps in recognition of daylight saving time.

Could the key to fighting modern illnesses lie in a disease that was an epidemic centuries ago?

Fifteen hospitals that use insulin pens will participate in ASHP's Mentored Quality Improvement Impact Program for Insulin Pen Safety.

New guidelines prioritize treatment options and preventive therapies for reducing the risk of COPD exacerbations in at-risk patients.

American Heart Association/American Stroke Association and The Children's Heart Foundation set to join forces in the fight against congenital heart defects

Transmission of the Ebola virus remains widespread in West Africa, with infections among health care workers continuing to rise.

Although only 38% of respondents to a recent Pharmacy Times poll have ever reported an armed robbery at their pharmacies, the experience remains jarring for those who do report the crime.

The FDA's Cardiovascular and Renal Drugs Advisory Committee has recommended the approval of edoxaban (Savaysa) for treating patients with nonvalvular atrial fibrillation, a type of arrhythmia that can potentially cause a stroke.

Students at MCPHS University celebrated American Pharmacists Month.

Three industry groups have collaborated to generate new approaches to care delivery through pharmacists that will lower medical costs and improve health outcomes.

Xigduo XR combines 2 anti-hyperglycemic agents with complementary mechanisms of action.

QS/1 is taking PCI data protection to the next level for its customers by partnering with ANX, an industry leader in helping pharmacies and small retail businesses secure and protect systems and networks from data breaches.

Sometimes, the pharmacist just can't leave the counter. At certain locations, that dedication persists even after death, leading to tales of spectral pharmacists causing mischief and strange events at their former pharmacies.

Leading groups fighting chronic disease argue that Congress intended for eligible consumers to receive tax credits that help make health coverage bought in either federal or state-run marketplaces more affordable.

Police have taken suspects into custody in conjunction with recent armed robberies at Rite Aid and CVS pharmacies.

The World Health Organization convened a high-level emergency meeting with government leaders and pharmaceutical company representatives earlier this week to discuss issues surrounding access to experimental Ebola vaccines.

Pfizer's serotonin and norepinephrine reuptake inhibitor, desvenlafaxine (Pristiq), has low potential for causing sexual dysfunction in patients with major depressive disorder.

Asthmatics with vitamin D deficiency are significantly more susceptible to acute asthma attacks.

Members of Congress have launched an investigation into the increasing generic drug prices that are plaguing both patients and pharmacists.